ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 128 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,538,324 | -74.8% | 662,529 | -61.8% | 0.01% | -75.9% |
| Q2 2023 | $18,007,505 | +65.5% | 1,736,500 | +29.1% | 0.05% | +58.8% |
| Q1 2023 | $10,877,814 | -61.3% | 1,344,600 | -24.6% | 0.03% | -64.2% |
| Q4 2022 | $28,075,950 | -3.8% | 1,782,600 | -3.8% | 0.10% | -18.8% |
| Q3 2022 | $29,170,000 | +20.5% | 1,853,251 | +6.9% | 0.12% | +14.7% |
| Q2 2022 | $24,205,000 | -38.3% | 1,733,900 | -23.9% | 0.10% | -34.6% |
| Q1 2022 | $39,257,000 | +320.0% | 2,277,100 | +254.2% | 0.16% | +321.6% |
| Q4 2021 | $9,348,000 | +32.7% | 642,900 | +64.3% | 0.04% | +19.4% |
| Q3 2021 | $7,043,000 | -16.2% | 391,300 | -18.2% | 0.03% | -18.4% |
| Q2 2021 | $8,404,000 | +1.7% | 478,600 | +46.0% | 0.04% | -2.6% |
| Q1 2021 | $8,261,000 | +53.3% | 327,800 | +21.4% | 0.04% | +77.3% |
| Q2 2018 | $5,390,000 | -57.9% | 269,922 | -63.0% | 0.02% | -58.5% |
| Q1 2018 | $12,796,000 | -34.5% | 730,374 | -7.8% | 0.05% | -36.9% |
| Q4 2017 | $19,531,000 | -15.2% | 792,000 | -11.2% | 0.08% | -18.4% |
| Q3 2017 | $23,030,000 | -1.5% | 892,298 | +3.5% | 0.10% | -21.4% |
| Q2 2017 | $23,388,000 | +70.5% | 862,402 | +87.5% | 0.13% | +72.4% |
| Q1 2017 | $13,715,000 | – | 459,916 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |